Clinical Trial Update: A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial of an adsorbed cell-free five-component DPT vaccine conducted by CanSino Biologics Inc. is currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• Adsorbed Cell-free DPT Vaccine (Five-component)

Snippet

Sponsor: CanSino Biologics Inc. | Conditions: Diphtheria, Tetanus | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING